Metrion Biosciences, a leading preclinical drug discovery contract research organization (CRO) specializing in ion channel screening, cardiac safety assessments, and neuroscience assays, has successfully raised £2,250,000 in funding. This significant investment underscores the industry’s confidence in Metrion's innovative approach to drug discovery and its commitment to advancing safety and efficacy profiles of emerging therapeutics. The funds will be strategically utilized to enhance and expand Metrion's cutting-edge in vitro screening services, which includes GLP hERG testing, the CiPA panel of human cardiac ion channels, and neurotoxicology evaluations. By scaling operations and integrating new technologies, Metrion aims to further optimize their service offerings and solidify their position as a trusted partner for pharmaceutical and biotechnology companies navigating the complexities of preclinical drug development. With a team that collectively brings over 250 years of expertise in managing ion channel research programs, Metrion prides itself on delivering flexible, cost-effective solutions tailored to meet client needs. This funding infusion will not only bolster Metrion’s capabilities but also enhance its role in ensuring that drugs entering clinical trials are both safe and effective, ultimately contributing to better healthcare outcomes. As the company embarks on this new chapter of growth, stakeholders can look forward to innovative advancements in drug discovery that prioritize patient safety and scientific excellence.
Breaking News: Metrion Biosciences Secures $2.25 Million in Funding for Cutting-Edge Drug Discovery Services
Recently funded · £2.3MBiotechnology
Get the full Metrion Biosciences company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
